Perioperative medication management

Medical Clinics of North America

Volumn 87, Issue 1, 2003, Pages 41-57

  Mercado, Donna L ^a   Petty, Brent G ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; AMINOPHYLLINE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ANTIRETROVIRUS AGENT; ANTIRHEUMATIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GLYCERYL TRINITRATE; HERBACEOUS AGENT; HORMONE; METFORMIN; MONTELUKAST; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

AGITATION; ANTICHOLINERGIC EFFECT; ANXIETY; BLEEDING; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; ENDOCRINE DISEASE; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPOTHYROIDISM; INSOMNIA; LACTIC ACIDOSIS; LUNG DISEASE; MENTAL DISEASE; NAUSEA; OSTEOPOROSIS; PARKINSON DISEASE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SEIZURE; SIDE EFFECT; TACHYCARDIA; THROMBOEMBOLISM; THROMBOSIS; VOMITING; WITHDRAWAL SYNDROME;

ANTI-HIV AGENTS; ANTIRHEUMATIC AGENTS; CARDIOVASCULAR AGENTS; DRUG THERAPY; HEMATOLOGIC AGENTS; HORMONES; HUMANS; INSULIN; INTRAOPERATIVE COMPLICATIONS; PHARMACOKINETICS; PHYTOTHERAPY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PSYCHOTROPIC DRUGS; RESPIRATORY SYSTEM AGENTS;

EID: 0037255013     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00146-3     Document Type: Review

References (45)

1. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148-53.
2. Stoller JK. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;346:988-94.
3. Smith MS, Muir H, Hall R. Perioperative management of drug therapy. Drugs 1996;51: 238-59.
4. Taggart DP, Siddiqui A, Whaeatley DJ. Low-dose preoperative aspirin therapy, post-operative blood loss, and transfusion requirements. Ann Thorac Surg 1990;50:425-8.
5. Physicians Desk Reference. Montvale, NJ: Medical Economics Company; 2002.
6. Abu-Hajir M, Masseo AJ. The pharmacology of anti-thrombotic and antiplatelet agents. Anesth Clin North Am 1999;17:749-86.
7. Horlocker TT, Wedel DJ. Neurological complications of spinal and epidural anesthesia. Reg Anesth Pain Med 2000;25:83-98.
8. Enneking FK, Benzon H. Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med 1998;23(Suppl 2):140-5.
9. Horlocker TT, Wedel DJ. Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med 1998;23(Suppl 2): 164-77.
10. Liu SS, Mulroy MF. Neuraxial anesthesia in the presence of standard heparin. Reg Anesth Pain Med 1998;23(Suppl 2):157-63.
11. Rosenquist RW, Brown DL. Neuraxial bleeding: fibrinolytics/thrombolytics. Reg Anesth Pain Med 1998;23(Suppl 2):152-6.
12. Urmey WF, Rowlingson J. Do antiplatelet agents contribute to the development of perioperative spinal hematoma? Reg Anesth Pain Med 1998;23(Suppl 2):146-51.
13. Haynes B, Dowsett M. Clinical pharmacology of selective estrogen receptor modulators. Drugs Aging 1999;14:323-36.
14. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
15. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increase risk for venous thromboembolic disease. Ann Intern Med 2000;132:689-96.
16. Spell NO. Stopping and restarting medications in the perioperative period. Med Clin North Am 2001;85:1117-28.
17. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Dept. of Health and Human Services, 2002, 21.
18. Ang-Lee MK, Moss J, Yuan C-S. Herbal medicines and perioperative care. JAMA 2001;286:208-16.
19. Tsen LC, Segal S, Pothier M, et al. Alternative medicine use in presurgical patients. Anesthesiology 2000;93:148-51.
20. Crove S, Fitzpatrick G, Jamaluddin MF. Use of herbal medicines in ambulatory surgical patients. Anaesthesia 2002;57:203-4.
21. Kaye AD, Heavner JE, Sabar R. Nutraceuticals and risk of neuraxial bleeding. Reg Anesth Pain Med 2001;26:92-3.
22. O'Hara MA, Kiefer D, Farrell K, et al. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998;7:523-36.
23. Ernst E, Pittler MH. Herbal medicine. Med Clin North Am 2002;86:149-61.
24. Fessenden JM, Wittenborn W, Clarke L. Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001;67:33.
25. Haller CA, Banowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833-8.
26. Taylor CL. FDA letter to health care professionals Available at: http://www.cfscan.fda.gov/~dms/ds-ltr29 Accessed March 25, 2002.
27. Cheng TO. Herbal interactions with cardiac drugs. Arch Int Med 2000;160:870.
28. Vickers A, Zollman C. Herbal medicine. Brit J Med 1999;319:1050-1053.
29. Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignant like syndrome due to levodopa therapy withdrawal. JAMA 1985;254:2792-5.
30. Waters C. Catechol-O-methyltransferase inhibitors in Parkinson's disease. J Am Geriat Soc 2002;48:692-8.
31. Bell RD, Merli GJ. Perioperative assessment and management of the surgical patient with neurologic problems. In: Merli GJ, Weitz HH, editors. Medical management of the surgical patient. 2nd edition. Philadelphia, PA: W.B. Saunders Co.; 1998. p. 2183-312.
32. Arar MG, Dairi Y, Corman LC. Perioperative management of neurologic conditions and complications. In: Gross RJ, Caputo GM, editors. Kammerer and Gross' medical consultation. 3rd edition. Maryland: Williams and Wilkins, Maryland; 1998. p. 553-6.
33. Drugs for psychiatric disorders. The Medical Letter 1986;28(725):99-105.
34. Edwards RP, Miller RD, Roizen MF, et al. Cardiac responses to imipramine and pancuronium during anesthesia with halothane and enflurane. Anesth 1979;50:421-5.
35. Michaels I, Serrins M, Shier NQ, et al. Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors. Anesth Analg 1984;63:1041-4.
36. El-Ganzouri AR, Ivankovich AD, Braverman B, et al. Monoamine oxidase inhibitors: should they be discontinued preopertively? Anesth Analg 1985;64:592-6.
37. Sarko J. Antidepressants, old and new. Emerg Med Clin North Am 2000;18:637-54.
38. Goldberg JF. New drugs in psychiatry. Emerg Med Clin North Am 2000;18:211-32.
39. Stoudemire A, Fogel BS, Gulley LR, et al. Psychopharmacology in the medically ill. In: Psychopharmacology in the medically ill. In: Stoudemire A, Fogel BS, editors. Psychiatric care of the medical patient. New York: Oxford University Press; 1993. p. 155-206.
40. Cygan R, Waitzkin H. Stopping and restarting medications in the perioperative period. J of Gen Int Med 1987;2:270-83.
41. McGlynn TJ, Simons RJ. Endocrine Disorders. In: Kammerer WS, Gross RJ, editors. Medical consultation. 1st edition. Baltimore, MD: Williams and Wilkins; 1990. p. 275-309.
42. Wall RT. Unusual endocrine problems. Anesth Clin North Am 1996;14:471-93.
43. McGlynn TJ, Simons RJ. Endocrine disorders. In: Gross RJ, Caputo GM, editors. Kammerer and Gross' medical consultation. 3rd edition. Maryland: Williams and Wilkins; 1998. p. 334-40.
44. Grennan DM, Gray J, Loudon J, et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Ann Rheum Dis 2001;60:214-7.
45. Wluka A, Buchbinder R, Hall S, et al. Methotrexate and postoperative complications. Ann Rheum Dis 2002;61:86-7.